The Genetics of Fetal Alcohol Spectrum Disorders by Eberhart, Johann K. & Parnell, Scott E.
The Genetics of Fetal Alcohol Spectrum Disorders (FASD)
Johann K. Eberhart, Ph.D.1 and Scott E. Parnell, Ph.D.2
1Department of Molecular Biosciences; Institute for Cell and Molecular Biology; Institute for 
Neuroscience; Waggoner Center for Alcohol and Addiction Research, University of Texas at 
Austin
2Bowles Center for Alcohol Studies; Department of Cell Biology and Physiology, University of 
North Carolina, Chapel Hill
Abstract
Background—The term Fetal Alcohol Spectrum Disorders (FASD) defines the full range of 
ethanol-induced birth defects. Numerous variables influence the phenotypic outcomes of 
embryonic ethanol exposure. Among these variables, genetics appears to play an important role 
yet our understanding of the genetic predisposition to FASD is still in its infancy.
Methods—We review the current literature that relates to the genetics of FASD susceptibility and 
gene-ethanol interactions. Where possible, we comment on potential mechanisms of reported 
gene-ethanol interactions.
Results—Early indications of genetic sensitivity to FASD came from human and animal studies 
using twins or inbred strains, respectively. These analyses prompted searches for susceptibility loci 
involved in ethanol metabolism and analyses of candidate loci, based on phenotypes observed in 
FASD. More recently, genetic screens in animal models have provided additional insight into the 
genetics of FASD
Conclusions—Understanding FASD requires that we understand the many factors influencing 
phenotypic outcome following embryonic ethanol exposure. We are gaining ground on 
understanding some of the genetics behind FASD, yet much work remains to be done. Coordinated 
analyses using human patients and animal models are likely to be highly fruitful in uncovering the 
genetics behind FASD.
Introduction
Alcohol exposure is the most common cause of environmentally induced human birth 
defects. Despite this, it was not appreciated until 1968 that a suite of birth defects may be 
associated with prenatal ethanol exposure (Lemoine et al., 1968) and 1973 when Fetal 
Alcohol Syndrome (FAS) was clinically recognized (Jones and Smith, 1973). We now know 
that ethanol can cause a wide range of birth defects, that are collectively referred to as Fetal 
Alcohol Spectrum Disorders (Riley et al., 2011).
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While ethanol exposure causes FASD, not all exposures result in recognizable FASD. For 
instance only 4.3% of children with heavy exposure to ethanol will develop full blown FAS 
(Abel, 1995), suggesting additional susceptibility factors are involved. As early as 1988, an 
indication of a role of genetics in susceptibility to FAS was identified due to families with a 
child with FAS being dramatically more likely to have a second child with FAS (Abel, 
1988). While genetics is merely one possible reason for this association, twin studies 
provided compelling evidence for genetics. In a study of monozygotic and dizygotic twins, 
monozygotic twins were 100% concordant for diagnosis while dizygotic twins were only 
64% concordant (Streissguth and Dehaene, 1993). This study strongly suggests that genetic 
loci regulating susceptibility to, or resistance against, FASD must be present in the human 
population.
Similar to humans, the initial evidence for genetic basis for FASD in animal models came 
from studies of closely related individuals. Inbreeding has generated strains of organisms 
with high levels of homozygosity within the strain. Either through selective breeding or 
genetic drift in isolated populations, numerous substrains of rodents, chicks and fish have 
arisen in the scientific community. Amongst these strains and substrains of any particular 
species there are differences in their inherent susceptibility to the teratogenic effects of 
developmental ethanol exposure. Interestingly, the susceptibility to the effects of ethanol 
often depend on the dependent variable tested and the time of exposure. As we examine 
these strains, their respective genetic differences and careful attention to the relevant 
embryology and developmental neurobiology will assist in identifying either specific 
mechanisms or genetic pathways involved in ethanol’s teratogenesis at specific 
developmental stages and on particular systems.
One of the first studies demonstrating strain differences was by Chernoff (1980), who 
maintained three strains of mice on a liquid diet containing ethanol prior to and throughout 
pregnancy and then examined the incidence and severity of fetal abnormalities. The CBA/J 
strain exhibited the most abnormalities, followed by C3H/lg mice and then the C57BL/6J 
strain. Not surprisingly, the incidence of defects was directly related to maternal blood 
alcohol concentration (BAC) and inversely related to liver ADH activity. It is unknown if the 
pregnant dams consumed the same amount of diet, and thus alcohol, but assuming they did, 
this study indicates a significant maternal factor, rather than fetal factors.
Since this characterization, numerous other studies since have compared the relative 
teratogenicity of ethanol in various strains of mice and have kept the amount of alcohol 
consistent. In a comparison of C57BL/10 vs. DBA/1 mice following early gestational 
ethanol exposure, both strains exhibited lower thresholds to audiogenic seizures, but this 
effect was much greater in the C57BL/10 mice, possibly due to an altered serotonergic 
system (Yanai, 1983). The C57BL/10 mice were also hypoactive, whereas the DBAs were 
not, and while both strains demonstrated reduced predatory behavior, this effect was much 
greater in the DBA strain. The various C57 substrains are consistently more susceptible to 
the effect of developmental ethanol exposure. In a whole embryo culture model of 
neurulation-stage ethanol exposure, both the C57BL/6N and DBA/2 strain exhibited 
significant malformations of the forebrain, optic system and hindbrain, although there was a 
differential sensitivity outside of the central nervous system (Ogawa et al., 2005). However, 
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a later study by this group with a narrower exposure window found delays of the forebrain, 
optic vesicle, midbrain hindbrain, and other derivatives of the caudal neural tube in the 
C57BL/6N strain, but only forebrain and optic vesicle deficiencies in the DBA/2 strain, 
while the 129S6/SvEvTac strain was not affected at all (Chen et al., 2011). These studies 
demonstrated interesting rostrocaudal and exposure period differential susceptibility that 
could be leveraged to focus on more specific mechanisms and genetic differences.
The C57BL/6J mice, one of the original C57 strains, were the first to be shown capable of 
recapitulating the craniofacial aspects of FAS and are more susceptible to ethanol 
teratogenesis during neurulation than many other strains, including, DBA/2, short-sleep, 
long-sleep, A/J, A/lbg, and 129S6 mice (Boehm et al., 1997; Downing et al., 2009; Downing 
et al., 2012; Sulik et al., 1981). In fact, the C57BL/6J mice are probably the most susceptible 
of the C57 sub-strains as demonstrated in a recent study comparing the C57BL/6J and 
C57BL/6N sub-strains during gastrulation-stage exposure, where the 6J mice exhibited 
ocular defects (rostrally-derived structures) at nearly twice the rate of their 6N counterparts 
(Dou et al., 2013). Finally, a recent experiment involving embryo transfers between 
C57BL/6J and DBA/2 mice confirmed that, with the possible exception of the maternal 
alcohol metabolizing enzymes, it is the genotype of the embryo and not the maternal 
genotype that is a more critical genetic determinant of an individual’s susceptibility to 
ethanol’s teratogenesis (Gilliam, 2014).
Rats have also been useful in assessing genetic contributions to FASD. In a third trimester 
equivalent model, the MR strain of rat demonstrated significant cerebellar deficiencies 
similar to the well-characterized Sprague-Dawley rat, whereas the M520 was less affected 
(Goodlett et al., 1989). However, the M520s exhibited body and brain growth restrictions by 
adulthood, perhaps demonstrating abnormalities of the pituitary gland, a structure partially 
derived from more rostral midline structures. While the anatomical defects are unknown, 
alcohol exposure throughout gestation increased seizure susceptibility in a strain of rat 
specifically bred to be more prone to convulsive epilepsies, while the WAG/Rij strain did not 
demonstrate this effect (Russo et al., 2008). Many FASD studies have been performed in the 
Sprague-Dawley rat, and two substrains of this strain have been developed that differ in their 
susceptibility to a neurulation-stage ethanol exposure (Wentzel and Eriksson, 2008). While 
these substrains metabolize ethanol at different rates, the more susceptible U strain still 
exhibited a greater incidence of ethanol-induced birth defects in an embryo culture system. 
Follow-up comparisons of these closely related sub-strains could reveal important ethanol 
susceptibility genes.
Strain-dependent susceptibility to the effects of developmental ethanol exposure are not 
restricted to rodents. A study by Debelak and Smith (2000) examined 11 strains of chick 
embryos following ethanol exposure during early neurulation and found that the strains 
could be classified into very sensitive, moderately sensitive or insensitive to ethanol-induced 
apoptosis of cranial neural crest cells, which give rise to facial structures. Another study in 
gastrulation-stage embryos found that the craniofacial effects of these various strains can be 
separated into those who exhibit midfacial flattening, overall facial flattening, or even facial 
expansion (Su et al., 2001). Interestingly, in this latter study it appears that more factors than 
apoptosis alone contribute to facial morphology as some strains that had excessive ethanol-
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induced apoptosis did not have any facial dysmorphology and degree of facial 
dysmorphology in susceptible strains did not correlate with the amount of apoptosis. It is 
possible that the gastrulation-stage exposure results in a down-regulation of Shh, which is 
necessary for normal face and brain development, or that both mechanisms act together. 
Subsequent transcriptomic comparisons of two chick strains, one susceptible [W98S] and 
one resistant [W98D], during late neurulation revealed numerous strain differences, mostly 
in genes involved in ribosome biosynthesis, among many others, demonstrating the potential 
of this approach in elucidating underlying genetic susceptibilities (Garic et al., 2014).
Due to external fertilization, ease in genetic and transgenic procedures and their similarity 
during early development to mammals, zebrafish are an excellent model in which to study 
FASD susceptibility genes. As with other species, fish also have multiple strains that differ 
in their sensitivity to developmental ethanol exposure. The first study examined three strains 
of zebrafish (EK, AB and TU) for survival and craniofacial malformations following ethanol 
exposure (Loucks and Carvan, 2004). The EK strain exhibited the most cell death, and both 
the EK and AB strains had more craniofacial malformations than the TU strain. 
Interestingly, different craniofacial skeletal elements were affected by ethanol exposure in 
each strain, a finding that could assist in uncovering both genetic factors and mechanisms. 
The lower amount of craniofacial dysmorphology in the TU strain may be due to increased 
embryo lethality in the TU strain (i.e., ethanol may be killing the most-affected embryos). 
However, another study demonstrated that a shorter exposure to alcohol resulted in 
significantly different brain neurochemistry in the AB strain, while the TU strain was 
resistant to the effects of ethanol (Mahabir et al., 2014). Further demonstration of the EK 
strain’s sensitivity has also been shown in a study of ethanol during eye morphogenesis 
(Arenzana et al., 2006).
Defining differences among various strains in terms of their sensitivity to developmental 
ethanol exposure is most useful if we actually know the genetic differences among these 
strains. Luckily, we are at a point where we can begin to explore these genetic differences 
using technologies such as whole transcriptome sequencing (RNA-seq) and other high-
throughput sequencing techniques. However, it must be cautioned that as we go forward 
with these studies that we are aware of potential strain differences in developmental 
trajectories, particularly in early development. For example, the C57BL/6N substrain begins 
gastrulation approximately 6 hours sooner than does the closely related C57BL/6J substrain 
(Dou et al., 2013). In rapidly developing species such as mice or fish, a 6 hour difference is 
substantial in terms of early embryonic events. Likewise, researchers should pay careful 
attention to the relevant embryology/developmental biology and ensure that we are studying 
the appropriate areas/cell types from which an affected structure is derived. If we design our 
studies carefully, we can make great progress in understanding specific genes that modify 
susceptibility to prenatal ethanol exposure.
FASD Genetics
Despite the magnitude of the problem, our understanding of the genetics underlying FASD is 
still very much in its infancy. Here, we provide a background and evidence of gene-ethanol 
interactions causing FASD in humans and animal models (See Table 1 for a current list of 
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genes shown to modulate the teratogenicity of ethanol). As with the classic definition of 
gene-gene interactions, a gene-ethanol interaction merely relates to a resulting phenotype 
and should not be taken to mean a direct physical binding of a gene product and ethanol. 
Indeed, for some of these interactions, the endogenous gene product is nonexistent and 
therefore physical interactions are impossible. Reciprocally, the physical binding of ethanol 
to a gene product would not necessarily have to lead to a genetic interaction, although 
physical binding is one possible mechanism for a genetic interaction. For the vast majority 
of the gene-ethanol interactions discussed here, we do not know the precise molecular 
mechanisms that lead to ethanol-induced phenotypes. However, where possible we comment 
on potential causes of these gene-ethanol interactions.
Genes involved in ethanol metabolism
Ethanol is cleared from the body first by its conversion to the highly reactive and toxic 
acetaldehyde, which is, in turn, converted to acetate. The predominant enzyme involved in 
alcohol conversion to acetaldehyde is Alcohol Dehydrogenase (ADH), with CYP2E1 and 
Catalase playing smaller roles. Acetaldehyde is subsequently converted to acetate via 
Aldehyde Dehydrogenase (ALDH). Studies in mouse have shown that inhibition of Adh 
activity but not Aldh increases the teratogenicity of ethanol (Ukita et al., 1993; Webster et 
al., 1983), suggesting that the clearance of alcohol itself is critical to avoid teratogenesis. On 
the other hand, direct administration of acetaldehyde is teratogenic in both mouse and 
zebrafish (Reimers et al., 2004; Webster et al., 1983), suggesting there may be some role for 
this metabolite in FASD. However, across several strains of chickens levels of acetaldehyde 
had to be beyond physiological levels to cause embryo malformations (Hartl and Shibley, 
2002). Ethanol-exposure alters the activity of Adh and Aldh enzymes in rat (Boleda et al., 
1992; Messiha and Varma, 1983), further complicating which metabolic enzymes are most 
relevant to FASD. Thus, there is mixed evidence for the actual teratogenic agent associated 
with ethanol consumption. It is likely that, depending upon context, either ethanol or 
acetaldehyde can be teratogenic and that until ethanol is metabolized to acetate the 
developing embryo is susceptible to harm.
In the human population, the rate of metabolism of these teratogenic substances may vary 
due to allelic differences in alcohol metabolizing enzymes. A more complete discussion of 
these alleles and their rates of metabolism can be found elsewhere (Warren and Li, 2005). 
While alleles of ADH and ALDH effect the overall risk of alcoholism (Crabb et al., 2004), 
to date the focus of study in human FASD has been on the major ethanol metabolic enzyme, 
ADH1.
ADH1 forms as a complex of proteins synthesized from three loci: ADH1A, ADH1B and 
ADH1C. Three alleles of both ADH1C and ADH1B have been described each with differing 
affinities for alcohol (Crabb et al., 2004). Of these, only the three alleles of ADH1B have 
been tested for the rate of clearance of ethanol in humans. In a Japanese population, 
individuals carrying ADH1B*2 or ADH1B*3 alleles cleared ethanol at a significantly higher 
rate than individuals homozygous for ADH1B*1 (Neumark et al., 2004), consistent with 
their in vitro kinetics (Crabb et al., 2004). However, in other studies examining African 
American individuals there were no significant differences in clearance based on ADH1B 
Eberhart and Parnell Page 5













genotype (Marshall et al., 2014; McCarthy et al., 2010; Taylor et al., 2008). These apparent 
differences could be due to study population or sample size differences, although it also 
likely that the genotype at a single locus will not be completely predictive of overall ethanol 
clearance. Regardless, enzymes affecting the rate at which alcohol and/or acetaldehyde are 
cleared remain likely candidate loci regulating FASD susceptibility.
In humans, there is evidence that ADH alleles predicted to rapidly metabolize ethanol 
protect against FASD. The ADH1B*2 allele is significantly underrepresented in mothers and 
their non-FAS-affected children (Viljoen et al., 2001). Maternal genotypes with at least one 
ADH1B*3 allele also correlate with a lower incidence of FASD (Das et al., 2004; Jacobson 
et al., 2006; McCarver et al., 1997). These studies differ in whether offspring genotype 
associated with outcome. Similarly, the slow metabolizing ADH1C variant, ADH1C*2, 
associates with increased risk of ethanol-associated oral clefting (Boyles et al., 2010). In 
contrast, a different study suggests that a maternal ADH1B*1/ADH1B*3 genotype is the 
most susceptible to having offspring with FASD (Stoler et al., 2002). While there are 
associations of differing ADH alleles with overall alcohol consumption, which could 
complicate some of these findings (Jacobson et al., 2006; Stoler et al., 2002; Warren and Li, 
2005), at least 3 of these studies showed no differences in reported overall drinking across 
genotypes (Boyles et al., 2010; Das et al., 2004; McCarver et al., 1997). Collectively, this 
provides support for an involvement of ADH alleles in FASD, with alleles predicted to 
metabolize ethanol more quickly being underrepresented in FASD. The precise nature of this 
correlation remains unknown. Unfortunately, there are no reports on genetic interactions 
with ADH causing FASD in animal models, which could help resolve these results.
The animal data available on ethanol metabolizing enzymes have focused on Aldh and 
highlight the potential for complex interactions of maternal and zygotic genotypes in the 
genesis of FASD. Fanconi anemia is a disease in human caused by mutation in any one of a 
number of FANC genes, whose products form an assembly that repairs DNA damage (Duxin 
and Walter, 2015). In mouse, Fancd2 interacts with Aldh2 in the susceptibility of embryos to 
FASD (Langevin et al., 2011). Aldh2−/−;Fancd2−/− and Aldh2+/−;Fancd2−/− pups born to 
Aldh2+/− dams had a significantly elevated occurrence of eye defects and exencephaly 
(Langevin et al., 2011). Other zygotic genotypes were not susceptible to these ethanol-
induced defects (Langevin et al., 2011). It is unclear if this complex interaction is involved 
in human FASD. However, it is interesting to note that individuals with Fanconi Anemia are 
predisposed to cancer due to DNA damage, predominantly due to reactive aldehydes, (Duxin 
and Walter, 2015) and rat models suggest that embryonic alcohol exposure may speed the 
acquisition of tumors (Polanco et al., 2010; Zhang et al., 2016). We know virtually nothing 
about the long-term health issues faced by individuals with FASD (Moore and Riley, 2015) 
and these findings may provide insight into these life long issues.
An alternative (or additional) potential mechanism for ADH-ethanol interactions
In 1991, two authors separately published a hypothetical cause of FASD in which alcohol 
teratogenicity involves ADH but is a secondary effect due to altered cell signaling. ADH is 
also responsible for the conversion of retinol (vitamin A) into retinaldehyde, an essential 
step in the generation of retinoic acid. Because retinoic acid is a critical morphogen in the 
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development of many structures sensitive to ethanol teratogenesis (Cunningham and 
Duester, 2015), Duester and Pullarkat independently proposed that competition between 
ethanol and retinol for ADH could reduce retinoic acid levels, resulting in birth defects 
(Duester, 1991; Pullarkat, 1991). Several reports in a rat model, even prior to the publication 
of these hypotheses, demonstrated that maternal ethanol consumption alters the levels of 
some, but not all, RA pathway constituents in fetal tissues (Grummer et al., 1993; Grummer 
and Zachman, 1990, 1995). Most in support of the retinoic acid hypothesis is the finding that 
maternal ethanol consumption results in elevated levels of retinol but reduced levels of 
retinoic acid in fetal heart (DeJonge and Zachman, 1995) and that ethanol appears to alter 
the activity of RAR transgenic expression in cultured mouse embryos (Deltour et al., 1996). 
Increasing the levels of retinoic acid partially restores development in avian, amphibian and 
fish models of FASD (Aksamija et al., 2009; Marrs et al., 2010; Muralidharan et al., 2015; 
Satiroglu-Tufan and Tufan, 2004; Twal and Zile, 1997) and, reciprocally, ethanol can reduce 
the teratogenicity of excess retinoic acid signaling in frog (Yelin et al., 2005). Collectively, 
results across different model systems support the hypothesis that ethanol can disrupt 
retinoic acid signaling.
The effect of ethanol on retinoic acid signaling may be highly dependent upon cell type. In 
contrast to the prediction of the retinoic acid hypothesis, ethanol greatly elevates the levels 
of retinoic acid in the hippocampus of fetal mice (Kane et al., 2010). Ethanol-induced 
microphthalmia in zebrafish is not rescued by elevating retinoic acid signaling (Kashyap et 
al., 2011; Zhang et al., 2015). Chen and colleagues found that while ethanol did inhibit the 
generation of retinoic acid from liver extracts, it failed to do so from zygotic extracts (Chen 
et al., 1996). Further, as noted below in “Candidate Genes: Facial Clefting in Humans”, in a 
human data set a receptor for retinoic acid failed to associate with ethanol and craniofacial 
defects (Etheredge et al., 2005). Thus, despite decades of study and the molecular evidence 
for the retinoic acid hypothesis it remains unknown if mutation of any pathway members 
associates with susceptibility to FASD.
The Genetics of Ethanol-Induced Facial Clefting in Humans
Drinking during pregnancy is a risk factor for isolated cleft lip with or without cleft palate 
(Munger et al., 1996). There has been extensive study into the genetics regulating orofacial 
development (Bush and Jiang, 2012) and several human studies have sought to determine if 
some of these candidate genes associated with ethanol and facial clefts. These studies have 
focused on members of the Transforming growth factor (TGF) pathway, the Bmp target, 
MSX1, and the Retinoic Acid receptor, RAR-α. In a study of 316 Danish children born with 
either cleft lip and/or palate, neither of the candidate genes TGF-β3 or MSX1 associated 
with ethanol usage and facial clefting (Mitchell et al., 2001). Similarly, a log-linear approach 
to more sensitively identify gene-environment interactions in a group of 222 children from 
Denmark with non-syndromic cleft lip/palate, failed to find association with TGF-β3 and 
MSX1 (Etheredge et al., 2005). This study also found no evidence for gene-ethanol 
interactions with RAR-α or TGF-α (Etheredge et al., 2005). Analyses of 214 cleft lip and/or 
palate cases in the Iowa birth defects registry found a significant association of ethanol 
consumption and MSX1, but not TGF-α or TGF-β3 in cleft lip and/or palate (Romitti et al., 
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1999). Thus, these candidate approaches in humans have had limited success in identifying 
loci mediating susceptibility to FASD.
There are even a more limited number of genome-wide association studies (GWAS) that 
have been performed to identify gene-ethanol interaction. In a GWAS analysis of 550 case-
parent trios of non-syndromic cleft palate cases for gene-environment interactions, SNPs in 
MLLT3 and SMC2 were significantly associated with ethanol usage and facial clefting 
(Beaty et al., 2011). MLLT3 contains a nuclear targeting sequence and translocation fusions 
between it and MLL result in leukemia (Strissel et al., 2000). In mouse, regions of the CNS, 
limb buds, facial prominences and skeletal primordia express Mllt3 and Mllt3 mutants have 
vertebral fusions consistent with disrupted Hox signaling (Collins et al., 2002), the facial 
skeleton was not specifically analyzed in these mice. SMC2 is part of the Structural 
Maintenance of Chromosomes gene family and functions in the Condensin complex 
(Hirano, 2002). This complex maintains chromosome condensation during mitosis and it 
critical for proper chromosome segregation (Hirano, 2002). SMC2 also appears to have non-
mitosis functions, as in vitro depletion of SMC2 disrupts nuclear shape (George et al., 
2014). To our knowledge, in vivo phenotypes of Smc2 loss-of-function in vertebrates are 
unknown, however RNAi-mediated knockdown of Smc2 results in increased death of 
embryonic stem cells (Fazzio and Panning, 2010). Continued genome-wide analyses in 
humans with follow-up analyses in animal models should help provide insight into how 
these genes and others are involved in FASD.
The Sonic Hedgehog (Shh) Pathway
Shh is a morphogen that, like retinoic acid, is critical for the development of many structures 
affected in FASD. A more extensive review of Shh signaling can be found elsewhere 
(Ingham and Placzek, 2006), but briefly Shh is a secreted ligand that binds the receptor 
Patched (Ptch). In the absence of ligand, Ptch represses the activity of the 7 pass 
transmembrane protein Smoothened (Smo). In the presence of ligand, Smo is derepressed 
and processes Gli transcription factors, notably Gli1 and Gli2, into activator forms to turn on 
gene expression. Other cell surface proteins, Cdon and Boc, act as Shh coreceptors and 
assist in activating the Shh pathway.
The Shh pathway was initially implicated in FAS due to phenotype. The facial and neural 
phenotypes associated with FAS in humans and animal models resemble those of 
holoprosencephaly (Sulik, 2014) and embryonic ethanol exposure is a risk factor for 
holoprosencephaly in humans (Cohen and Shiota, 2002). Most mutations known to cause 
holoprosencephaly disrupt the Shh pathway (Solomon et al., 2010). Further, a chicken model 
of FASD resulted in craniofacial defects and neural crest apoptosis similar to that observed 
when Shh signaling was blocked by antibodies (Ahlgren and Bronner-Fraser, 1999; 
Cartwright and Smith, 1995). In this system, ectopic application of Shh rescued these 
defects (Ahlgren et al., 2002). Collectively, these findings lead to the hypothesis that one 
teratogenic mechanism of ethanol was the inhibition of Shh signaling.
Despite these early indications of a role of Shh in ethanol teratogenesis, it wasn’t until a 
decade later that there was direct evidence for a genetic interaction between ethanol and the 
Shh pathway. Under normal conditions, loss of Cdon in a 129S6 genetic background only 
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results in mild defects similar to microform holoprosencephaly. This genotype is highly 
sensitive to ethanol exposure and displays profound neural and facial phenotypes covering 
the range of holoprosencephaly as well as palatal defects following embryonic ethanol 
exposure (Hong and Krauss, 2012). Wild-type and heterozygous littermates were largely 
normal in these analyses (Hong and Krauss, 2012). In a set of follow up experiments, the 
same group found that elevating Shh signaling by loss of a single allele of Ptch1 was able to 
restore proper development in ethanol-treated Cdon mutant embryos (Hong and Krauss, 
2013). In humans, haploinsufficiency for CDON causes holoprosencephaly (Bae et al., 
2011), however, ethanol only appears to exacerbate the homozygous mutant phenotype in 
this mouse strain (Hong and Krauss, 2012). The reason for this discrepancy is unclear, but it 
may relate to the use of the 129S6 genetic background because mouse Cdon mutants on a 
C57BL/6N background have more severe holoprosencephaly (Hong and Krauss, 2012).
In addition to CDON, haploinsufficiency of either GLI2 (Roessler et al., 2003) or SHH 
(Roessler et al., 1996) causes holoprosencephaly in humans. Under control conditions, 
mouse Shh and Gli2 heterozygotes develop normally (Chiang et al., 1996; Mo et al., 1997). 
However, heterozygosity for Shh significantly enhanced the facial and neural defects caused 
by ethanol and this enhancement was even more profound in Gli2 heterozygotes (Kietzman 
et al., 2014). Similar results are found in a zebrafish FASD model in which partial 
knockdown of shha via morpholinos sensitizes embryos to ethanol-induced neural 
differentiation defects (Zhang et al., 2013). Interestingly, ethanol does not appear to cause 
haploinsufficiency, at least for facial phenotypes, in zebrafish smo mutants (McCarthy et al., 
2013), but does appear to enhance facial defects in a hypomorphic shha mutant line (our 
unpublished results). Collectively, these results demonstrate that the Shh pathway does 
genetically interact with ethanol, but not all members of the pathway interact equally. The 
reason for this “inequality” is not clear, but has important implications in determining 
genetic risk for FASD in human populations.
There are several possibilities for why ethanol genetically interacts with the Shh pathway. 
As mentioned above, ethanol may compete with retinol for ADH (RADH), inhibiting 
retinoic acid production. Retinoic acid is initially critical for inducing Shh expression in the 
notochord and overlying neural plate and continues to be an important morphogen and 
signaling molecule throughout development. The developing forelimb also requires RA for 
initial induction of forelimb outgrowth, and reductions of RA, or inhibition of the RA 
receptor results in postaxial ectrodactyly (loss of digits) similar to prenatal ethanol exposure 
(Johnson et al., 2007). Exogenous RA administration can rescue at least some of these 
effects. Further proof of this as a causative mechanism for some of the more severe brain 
(e.g. holoprosencephaly), craniofacial and digital effects of ethanol exposure is that the 
timing of the ethanol exposure is just slightly prior to the onset of Shh expression. In 
contrast, direct inhibition of Shh signaling via cyclopamine, a potent Smo antagonist, 
induces holoprosencephaly only at slightly later stages of development, when Shh is actively 
expressed (Heyne et al., 2015; Lipinski et al., 2014). This mechanism would also explain 
why ethanol exposure reduces Shh expression during gastrulation, but apparently not during 
neurulation. It is still unclear if ethanol is preventing the induction of Shh expression 
through inhibition of RA production, or through another mechanism.
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A second possibility for an ethanol-induced disruption of the Shh pathway is based on the 
finding that Shh proteins must undergo post-translational modification in order to be 
properly packaged, secreted and to diffuse to its target cells (Dennis et al., 2012; Porter et 
al., 1996a; Porter et al., 1996b). One of these key modifications is the addition of cholesterol 
to the N-terminal end of Shh and the lack of this lipid modification results in altered Shh 
signal propagation. It was observed nearly 20 years ago that disruption of cholesterol 
homeostasis either through chemical inhibition of cholesterol biosynthesis during 
gastrulation or mutation of key cholesterol synthesis genes (i.e. DHRC7, which is mutated in 
Smith-Lemli-Opitz syndrome) results in dysmorphologies similar to those observed in 
ethanol exposure during gastrulation and these effects are likely exerted through the Shh 
pathway (Dehart et al., 1997; Lanoue et al., 1997; Porter et al., 1996b). This hypothesis is 
supported by the finding in zebrafish that ethanol can block the modification of Shh by 
cholesterol, resulting in decreased Shh pathway activation, and supplementation with 
cholesterol can rescue ethanol’s effects (Li et al., 2007). This same group has also 
demonstrated that ethanol exposure can inhibit Caveolin-1/Shh complexes (Mao et al., 
2009). Caveolin-1 is both dependent on, and modulates cholesterol homeostasis, and 
decreasing caveolin-1/Shh complexes results in decreased Shh secretion and subsequent 
signaling (Frank et al., 2006; Hailstones et al., 1998). Together, these data suggest that 
ethanol exposure can alter Shh signaling through a mechanism involving cholesterol, 
although more research is needed to fully understand this phenomenon.
Finally, the possibilities surrounding ethanol-induced cell death and disruptions in Shh 
signaling must also be considered. Ethanol has often been demonstrated to directly induce 
apoptosis at many periods of development (see below) and ethanol exposure during 
gastrulation has been shown to induce cell death in the general region of the embryo that 
will give rise to the face and brain (Dunty et al., 2001). However, at these early stages, these 
spatiotemporal data are difficult to interpret and it is not clear if these dying cells are 
causative or merely ancillary. For these reasons, it is unclear if ethanol is killing the cells 
expressing Shh or the cells receiving the Shh signal. Adding to the confusion is the fact that 
Shh itself is a potent cell survival factor and decreasing Shh expression, secretion or 
transduction may cause massive apoptosis secondary to the ethanol exposure (Delloye-
Bourgeois et al., 2014; Thibert et al., 2003). Some of our recent unpublished data has 
demonstrated that mice lacking either one or both copies of the pro-apoptotic gene Bax show 
an inverse gene dose-dependent resistance to the detrimental effects of a gastrulation-stage 
ethanol exposure. Additional data from our lab and others showing that reducing oxidative 
stress (e.g. through administration of NAC) can at least partially ameliorate the effects of 
ethanol during early gestation also point to a mechanism involving cell death (Chen et al., 
2013; Chen et al., 2015; Parnell et al., 2010; Wentzel and Eriksson, 2008; Wentzel et al., 
2006). These data showing a clear relation between apoptotic cell death and resiliency to 
ethanol-induced dysmorphology demonstrate that cell death may interact with Shh signaling 
to mediate ethanol’s teratogenesis. Regardless of the relationship, the idea of cell death must 
be considered alongside studies designed to investigate genes involved in modulating the 
effects of prenatal alcohol exposure.
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Nitric oxide synthase 1 (Nos1)
In vitro studies have shown that cerebellar granule cells are highly sensitive to ethanol-
induced cell death (Pantazis et al., 1993). While nitric oxide can be pro-apoptotic (Brune et 
al., 1998), it has been shown to protect neurons from apoptosis (Ciani et al., 2002), making it 
a candidate to protect against ethanol-induced neuronal cell death. Indeed, elevating nitric 
oxide levels protects against ethanol-induced cerebellar granule cell death (Pantazis et al., 
1998). This protective effect suggested that reduced nitric oxide could sensitize embryos to 
ethanol teratogenesis. Indeed, the ethanol-induced reduction in cortical, cerebellar and 
hippocampal size and neuronal cell loss was significantly more severe in Nos1 mutants, 
compared to wild-type embryos (Bonthius et al., 2002; Karacay et al., 2015). These 
cerebellar neuronal losses are associated with poorer performance on balance beam and 
rotorod tests, demonstrating an associated behavioral deficit (Bonthius et al., 2015). Thus, 
the genesis of neural and behavioral deficits in FASD may depend, at least partly, on nitric 
oxide signaling.
How ethanol interacts with the nitric oxide signaling pathway remains to be elucidated and 
is likely to be complex. In cultured cerebellar neurons, NF-kB signaling acts downstream of 
nitric oxide signaling, with activation of NF-kB being required for the protective effects of 
nitric oxide signaling (Bonthius et al., 2009). In a rat model of FASD, ethanol reduces the 
levels of DNA-bound NF-kB in the cerebellum (Acquaah-Mensah et al., 2002), suggesting a 
possible mechanism for the Nos1-ethanol interaction. However, in whole embryo mouse and 
Xenopus models of FASD, ethanol elevates the level of NF-kB (Peng et al., 2005; Zheng et 
al., 2014). Additionally, Nerve growth factor and Fibroblast growth factor 2, but not Brain-
derived neurotrophic factor, require nitric oxide signaling for their neuroprotective effects 
against ethanol (Bonthius et al., 2003). Thus, as is likely to be the case for most gene-
ethanol interactions, the Nos1-ethanol interaction is likely to be context dependent.
Platelet-derived growth factor receptor alpha (Pdgfra)/PI3K/mTOR
We recently combined a candidate gene and genetic screening approach to identify 
mutations that enhanced the teratogenicity of ethanol (McCarthy et al., 2013). We tested five 
mutants with disrupted facial development for ethanol sensitivity and discovered that pdgfra 
interacted strongly with ethanol. Notably, while under normal conditions pdgfra 
heterozygotes develop without defect, a normally subteratogenic dose of ethanol causes 
profound facial defects in two-thirds of heterozygous embryos (McCarthy et al., 2013). The 
strength of this interaction prompted us to examine a human dataset generated by the 
Collaborative Initiative on FASD, where we found strong support for gene-ethanol 
interactions with both PDGF receptors, PDGFRA and PDGFRB. Using zebrafish, we found 
that the pdgfra-ethanol interaction was synergistic in nature as ethanol greatly elevated the 
levels of apoptosis in mutants and heterozygotes relative to untreated mutants or ethanol-
treated wild-type embryos. These data provide compelling support in both a model organism 
and human that ethanol interacts genetically with the Pdgf signaling pathway.
Insight into how ethanol may interact with the Pdgf pathway came from in vitro work with 
ethanol and in vivo analyses in mouse and frog. In mouse, the major effector of Pdgfra 
signaling during facial development is PI3K (Klinghoffer et al., 2002) and PI3K functions 
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downstream of Pdgfra to promote survival of mesoderm in frog (Van Stry et al., 2005). PI3K 
can activate AKT, which in turn can activate mTOR, an important pathway in cell survival 
(Dibble and Cantley, 2015). In vitro studies have demonstrated that ethanol can inhibit the 
PI3K/AKT/mTOR pathway at multiple levels (Hong-Brown et al., 2010; Xu et al., 2003). 
We found that activation of this pathway rescued mutants from the effects of ethanol and that 
signaling at or downstream of mTOR was disrupted in ethanol-treated pdgfra mutants 
(McCarthy et al., 2013). This finding suggests that other growth factor pathways, such as 
Insulin, that use the PI3K/AKT/mTOR pathway are likely to be ethanol-sensitive loci. While 
this prediction has yet to be tested, elevating Insulin signaling protects against FASD in a 
Drosophila model (McClure et al., 2011) and ethanol reduces Insulin-PI3K signaling in 
cerebella of rat pups (Xu et al., 2003). Because PI3K/AKT/mTOR is a major pathway 
linking nutrient sensing and growth factor signaling, it is possible that multifactorial gene-
environment interactions through this pathway mediate FASD susceptibility.
Others
In a follow-up genetic screen, we determined if ethanol interacted with mutant lines of 
zebrafish available from the Zebrafish International Resource Center (Swartz et al., 2014). 
We screened 20 mutant lines and found that a minority of them, 5, interacted with ethanol to 
produce exacerbated facial and/or neural defects. Ethanol exacerbated the phenotypes of 
hinfp, foxi1, mars and plk1 mutants. The fifth mutant, vangl2, is a member of the Wnt 
Planar Cell Polarity (Wnt/PCP) pathway and interacted strongly with ethanol, causing 
cyclopia in all mutants and revealing haploinsufficiency. The cyclopic phenotype observed 
in the ethanol-vangl2 interaction closely parallels phenotypes observed in zebrafish embryos 
treated with high doses of ethanol (Blader and Strahle, 1998). The Wnt/PCP pathway is 
critical for regulating convergent/extension movements in the early embryo that elongate the 
body axis, and separate the eye fields in zebrafish. There are several reports of ethanol 
disrupting convergent/extension movements (Sarmah et al., 2013; Yelin et al., 2005). Thus, it 
is likely that combined genetic and environmental inhibition of Wnt/PCP signaling is 
responsible for the vangl2-ethanol interaction, yet the mechanism by which ethanol may 
inhibit Wnt/PCP signaling remains to be determined.
Concluding remarks
How extensive are gene-ethanol interactions? Or an oft-asked question: isn’t ethanol just 
making a sick embryo sicker? Due to the small size of ethanol and its pleiotropic effects it 
would seem possible that ethanol would interact with most genes. The collective body of 
work presented here though clearly demonstrates that not all genotypes are equally sensitive 
to ethanol. From the genetic screens that we have performed, where we have also reported 
on genes that did not appear to interact with ethanol, it would seem that only a minority of 
genes interacts with ethanol, at least for phenotypes we have examined. Six of the 25 loci 
that we have tested interacted with ethanol and only two of these showed haploinsufficiency. 
By their nature our screens have been skewed towards genes involved in early 
embryogenesis and, therefore, may be overrepresented in loci that predispose to FASD. Due 
to the high prevalence of FASD, homozygous null mutation at a locus is likely to only 
explain a tiny fraction of human FASD cases, therefore, haploinsufficiency may be a better 
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model of reduced gene function, caused by coding or enhancer variants in humans. Much 
more extensive shelf screens could give more accurate insight into the commonality of gene-
ethanol interactions, but based on our screens, it is likely that a low percentage of genes will 
interact strongly with ethanol. However, given the size of the human genome, currently 
estimated at 20,000 genes, even such a low percentage would result in many hundreds of 
ethanol sensitive loci. Clearly, much more work is needed to identify and characterize the 
effects of these genes involved in FASD susceptibility.
Given that many genes are likely to interact with ethanol, it might follow that there is no 
single functional type of gene that were sensitive to ethanol. Using the genes that have we 
have discussed that interact with ethanol, we performed gene function analysis in DAVID 
(https://david.ncifcrf.gov/home.jsp). This analysis examines co-occurrence between 
functional categories, such as gene ontology (GO) terms and a set of genes. Because Shh, 
Gli2 and Cdon are all part of the Hedgehog pathway, we only used Shh in the analyses to 
avoid skewing the dataset towards functions regulated by this pathway. This analysis 
uncovered 8 clusters of functional terms enriched in these ethanol-sensitive genes (See 
Supplemental File 1 for the raw data output). Fig. 1 lists these clusters in descending order 
of enrichment; clusters are named according to the general properties of the functional terms 
within the cluster (See Supplemental File 1 for a complete list). This analysis would suggest 
that there is not a defining functional characteristic of loci that genetically interact with 
ethanol. Continued identification of gene-ethanol interactions, in particular using unbiased 
approaches, will be critical to fully understand the many genetic functions that ethanol 
inhibits. However, it is of interest that these clusters relate to functional processes have been 
implicated in FASD (Dennery, 2007; Sant’Anna and Tosello, 2006; Shibley and Pennington, 
1997).
Why should we care about the genetics of FASD? Perhaps the most compelling reason is the 
fact that FASD is so widely variable in phenotypic outcome. We cannot fully appreciate how 
to deal with FASD medically unless we understand all of the factors that affect this 
phenotypic variability. As we understand how genetics leads to phenotypic outcomes, we 
will certainly be able to improve our diagnosis and ability to determine individual risk. 
Equally important, though, is that identifying a genetic interaction with ethanol gives insight 
into pathways, both genetic and signaling, that are causative of FASD and may provide 
interventions or preventatives against FASD.
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Table 1
List of Gene-ethanol interactions.
Gene(s) Species Phenotype Reference(s)
ADH1B Human FAS McCarver et al., 1997
Stoler et al., 2002
Das et al., 2004
Jacobson et al., 2006
ADH1C Human Oral clefting Boyles et al., 2010
MLLT3
SMC2
Human Oral clefting Beaty et al., 2011
Aldh2;Fancd2 Mouse Eye defects
Exencephaly








Hong and Krauss, 2012
Kietzman et al., 2014
Zhang et al., 2013
Nos1 Mouse Neural and behavioral Bonthius et al., 2002
Karacay et al., 2015
Bonthius et al., 2015
PDGFRA Human
Zebrafish








Swartz et al., 2014
*
denotes an interaction using a morpholino.
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